Journal Mobile Options
Table of Contents
Vol. 2, No. 3, 2009
Issue release date: September – December
Add to my selection Citation Download
Open Access Gateway
Case Rep Oncol 2009;2:210–216
(DOI:10.1159/000253866)
Published: November 2009

Mucinous Cystadenocarcinoma of the Breast with Estrogen Receptor Expression: A Case Report and Review of the Literature

Rakıcı S.a · Gönüllü G.b · Gürsel Ş.B.c · Yıldız L.d · Bayrak İ.K.e · Yücel İ.b
aDepartment of Radiation Oncology, Atatürk University Faculty of Medicine, Erzurum, Departments of bMedical Oncology, cRadiation Oncology, dPathology, and eRadiology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey Case Rep Oncol 2009;2:210–216 (DOI:10.1159/000253866)

Abstract

Primary mucinous cystadenocarcinoma (MCA) of the breast was first described by Koenig and Tavassoli in 1998. To our knowledge, only 9 cases of MCA of the breast have been reported. The optimal treatment of MCA could not be defined yet. This article aims to increase the knowledge about this rare variant of breast cancer and to review the literature.

 goto top of outline Author Contacts

Dr. Sema Rakıcı
Department of Radiation Oncology
Atatürk University Faculty of Medicine
TR–25240 Erzurum (Turkey)
Tel. +90 50 5402 8302, Fax +90 44 2236 0988, E-Mail sema.neslihan@gmail.com


 goto top of outline Article Information

Published online: November 14, 2009
Number of Print Pages : 7
Number of Figures : 4, Number of Tables : 1,


 goto top of outline Publication Details

Case Reports in Oncology

Vol. 2, No. 3, Year 2009 (Cover Date: September - December)

Journal Editor: Markman M. (Houston, Tex.)
ISSN: NIL (Print), eISSN: 1662-6575 (Online)

For additional information: http://www.karger.com/CRO


Open Access License / Drug Dosage

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.